Home › Ulcerative Colitis › New Hampshire
Ulcerative Colitis clinical trials in New Hampshire
5 studies for Ulcerative Colitis are looking for participants at sites in New Hampshire.
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Dartmouth-Hitchcock Medical Center, Lebanon
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 24, 2026 · NCT06937086Piloting an Insomnia Treatment in Patients With Ulcerative Colitis
- Dartmouth-Hitchcock Medical Center, Lebanon
Recruiting
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT07428629Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Dartmouth Hitchcock, Lebanon
Recruiting
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT05230173ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
- ALPCO, Salem
RecruitingObservational studyHealthy volunteers welcome
Ages 22 and older · All sexes · Updated Apr 28, 2026 · NCT06810518Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- Dartmouth Hitchcock Medical Center, Lebanon
Recruiting
Ages 18 to 85 · All sexes · Updated Jan 8, 2026 · NCT05987852From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.